Krischer, Jeffrey P.
University of South Florida
32 papers on CoChatORCID 0000-0003-4526-888X
Most cited papers
- Verified
Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 1,216
- Verified
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine
Diabetes and associated disordersT-cell and B-cell Immunology
Cited by 1,189
- Verified
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine
Tuberous Sclerosis Complex ResearchVascular Malformations and Hemangiomas
Cited by 1,099
- Verified
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2011) · The Lancet
Diabetes and associated disordersT-cell and B-cell Immunology
Cited by 612
- Verified
International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
Boycott, K. M., Rath, A., Chong, J. X., Hartley, T., Alkuraya, F. S., Baynam, G., Brookes, A. J., Brudno, M., Carracedo, A., den Dunnen, J. T., et al. (2017) · The American Journal of Human Genetics
Genomics and Rare DiseasesConnective tissue disorders research
Cited by 447
- Verified
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
the TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia
Diabetes and associated disordersDiabetes Management and Research
Cited by 444
- Verified
Clinical research for rare disease: Opportunities, challenges, and solutions
Griggs, R. C., Batshaw, M., Dunkle, M., Gopal-Srivastava, R., Kaye, E., Krischer, J., Nguyen, T., Paulus, K., & Merkel, P. A. (2009) · Molecular Genetics and Metabolism
Statistical Methods in Clinical TrialsGenomics and Rare Diseases
Cited by 401
- Verified
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Wherrett, D. K., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Marks, J. B., et al. (2011) · The Lancet
Diabetes and associated disordersDiabetes Management and Research
Cited by 371
- Verified
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Battaglia, M., Ahmed, S., Anderson, M. S., Atkinson, M. A., Becker, D., Bingley, P. J., Bosi, E., Brusko, T. M., DiMeglio, L. A., Evans-Molina, C., et al. (2020) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 351
- Verified
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia
Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism
Diabetes and associated disordersClinical Laboratory Practices and Quality Control
Cited by 291
- Verified
The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants
Hagopian, W. A., Erlich, H., Lernmark, Å., Rewers, M., Ziegler, A. G., Simell, O., Akolkar, B., Vogt, R., Blair, A., Ilonen, J., et al. (2011) · Pediatric Diabetes
Diabetes and associated disordersGenetic Associations and Epidemiology
Cited by 260
- Verified
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 260
- Verified
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer, J. P., Schatz, D. A., Bundy, B., Skyler, J. S., & Greenbaum, C. J. (2017) · JAMA
Diabetes and associated disordersDiabetes Management and Research
Cited by 214
- Verified
Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: the environmental determinants of diabetes in the young (TEDDY)
Steck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 185
- Verified
Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children
Bonifacio, E., Beyerlein, A., Hippich, M., Winkler, C., Vehik, K., Weedon, M. N., Laimighofer, M., Hattersley, A. T., Krumsiek, J., Frohnert, B. I., et al. (2018) · PLOS Medicine
Diabetes and associated disordersGenetic Associations and Epidemiology
Cited by 148
- Verified
A combined risk score enhances prediction of type 1 diabetes among susceptible children
Ferrat, L. A., Vehik, K., Sharp, S. A., Lernmark, Å., Rewers, M. J., She, J.-X., Ziegler, A.-G., Toppari, J., Akolkar, B., Krischer, J. P., et al. (2020) · Nature Medicine
Diabetes and associated disordersDiabetes Management and Research
Cited by 148
- Verified · note
TEDDY–The Environmental Determinants of Diabetes in the Young: An Observational Clinical Trial
HAGOPIAN, W. A., LERNMARK, Å., REWERS, M. J., SIMELL, O. G., SHE, J., ZIEGLER, A. G., KRISCHER, J. P., & AKOLKAR, B. (2006) · Annals of the New York Academy of Sciences
Diabetes and associated disordersDiabetes Management and Research
Cited by 125
- Verified
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients
Sosenko, J. M., Skyler, J. S., Palmer, J. P., Krischer, J. P., Yu, L., Mahon, J., Beam, C. A., Boulware, D. C., Rafkin, L., Schatz, D., et al. (2013) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 123
- Verified
Only Multiple Autoantibodies to Islet Cells (ICA), Insulin, GAD65, IA-2 and IA-2β Predict Immune-Mediated (Type 1) Diabetes in Relatives
Maclaren, N., Lan, M., Coutant, R., Schatz, D., Silverstein, J., Muir, A., Clare-Salzer, M., She, J.-X., Malone, J., Crockett, S., et al. (1999) · Journal of Autoimmunity
Diabetes and associated disordersDiabetes Management and Research
Cited by 117
- Verified
Β cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
Evans-Molina, C., Sims, E. K., DiMeglio, L. A., Ismail, H. M., Steck, A. K., Palmer, J. P., Krischer, J. P., Geyer, S., Xu, P., Sosenko, J. M., et al. (2018) · JCI Insight
Diabetes and associated disordersDiabetes Management and Research
Cited by 116
- Verified
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
Russell, W. E., Bundy, B. N., Anderson, M. S., Cooney, L. A., Gitelman, S. E., Goland, R. S., Gottlieb, P. A., Greenbaum, C. J., Haller, M. J., Krischer, J. P., et al. (2023) · Diabetes Care
Diabetes and associated disordersT-cell and B-cell Immunology
Cited by 108
- Verified
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies
Yu, L., Boulware, D. C., Beam, C. A., Hutton, J. C., Wenzlau, J. M., Greenbaum, C. J., Bingley, P. J., Krischer, J. P., Sosenko, J. M., Skyler, J. S., et al. (2012) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 104
- Verified
Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study
Vehik, K., Lynch, K. F., Schatz, D. A., Akolkar, B., Hagopian, W., Rewers, M., She, J.-X., Simell, O., Toppari, J., Ziegler, A.-G., et al. (2016) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 103
- Verified
A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history
Sosenko, J. M., Skyler, J. S., DiMeglio, L. A., Beam, C. A., Krischer, J. P., Greenbaum, C. J., Boulware, D., Rafkin, L. E., Matheson, D., Herold, K. C., et al. (2015) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 86
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free